Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications
Authors:
- Xin Gen LeiXin Gen Lei
- Jian-Hong ZhuJZJian-Hong Zhu
- Wen-Hsing ChengWCWen-Hsing Cheng
- Yongping BaoYBYongping Bao
- Ye-Shih HoYHYe-Shih Ho
- Amit R. ReddiARAmit R. Reddi
- Arne HolmgrenAHArne Holmgren
- Elias S. J. ArnérEAElias S. J. Arnér
Top Cited Papers
- 1 January 2016
- journal article
- review article
- Published by American Physiological Society in Physiological Reviews
- Vol. 96 (1) , 307-364
Abstract
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generated from aerobic metabolism, as a result of accidental electron leakage as well as regulated enzymatic processes. Because ROS/RNS can induce oxidative injury and act in redox signaling, enzymes metabolizing them will inherently promote either health or disease, depending on the physiological context. It is thus misleading to consider conventionally called antioxidant enzymes to be largely, if not exclusively, health protective. Because such a notion is nonetheless common, we herein attempt to rationalize why this simplistic view should be avoided. First we give an updated summary of physiological phenotypes triggered in mouse models of overexpression or knockout of major antioxidant enzymes. Subsequently, we focus on a series of striking cases that demonstrate “paradoxical” outcomes, i.e., increased fitness upon deletion of antioxidant enzymes or disease triggered by their overexpression. We elaborate mechanisms by which these phenotypes are mediated via chemical, biological, and metabolic interactions of the antioxidant enzymes with their substrates, downstream events, and cellular context. Furthermore, we propose that novel treatments of antioxidant enzyme-related human diseases may be enabled by deliberate targeting of dual roles of the pertaining enzymes. We also discuss the potential of “antioxidant” nutrients and phytochemicals, via regulating the expression or function of antioxidant enzymes, in preventing, treating, or aggravating chronic diseases. We conclude that “paradoxical” roles of antioxidant enzymes in physiology, health, and disease derive from sophisticated molecular mechanisms of redox biology and metabolic homeostasis. Simply viewing antioxidant enzymes as always being beneficial is not only conceptually misleading but also clinically hazardous if such notions underpin medical treatment protocols based on modulation of redox pathways.Keywords
Funding Information
- NIH (DK53018)
- Natural Science Foundation of China (#31320103920, #31310103026, #31201065)
- Zhejiang Provincial Natural Science Fund for Distiguished Young Scholars (LR13H020002)
- Cancer Prevention Research Trust, UK (#Bao)
- The Georgia Institute of Technology (Start-up Fund)
This publication has 749 references indexed in Scilit:
- Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusionBasic Research in Cardiology, 2012
- Thioredoxin‐80 is a product of alpha‐secretase cleavage that inhibits amyloid‐beta aggregation and is decreased in Alzheimer's disease brainEMBO Molecular Medicine, 2012
- SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent lipid peroxidation in diabetic embryopathyAmerican Journal of Obstetrics and Gynecology, 2011
- Irradiation enhances hippocampus‐dependent cognition in mice deficient in extracellular superoxide dismutaseHippocampus, 2010
- Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemiaGlia, 2010
- Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses Benzo(a)pyrene-accelerated atherosclerosisAtherosclerosis, 2009
- Antioxidant enzyme gene transfer for ischemic diseasesAdvanced Drug Delivery Reviews, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Evidence that a polymorphism within the 3′UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancerGenes & Nutrition, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007